Metabolomics in Prenatal Medicine: A Review

Area of Science:

• Prenatal medicine
• Metabolomics
• Biomarker discovery

Background:

• Pregnancy requires monitoring maternal and fetal well-being.
• Non-invasive prenatal tests with lower false-positive rates are crucial.
• Metabolomics analyzes biochemical products for diagnostic and therapeutic insights.

Purpose of the Study:

• To review and summarize metabolomics studies in prenatal diagnosis.
• To identify themes, controversies, and potential biomarkers.
• To assess the clinical utility of metabolomics in perinatology.

Main Methods:

• Comprehensive literature search of PubMed and Google Scholar (through January 2020).
• Keywords included metabolomics techniques (NMR, mass spectrometry) and prenatal conditions (aneuploidy, pre-eclampsia, fetal growth restriction).
• Analysis of studies published between 2000-2020, focusing on recent advancements.

Main Results:

• Metabolomics aids in identifying novel prenatal biomarkers and therapeutic targets.
• High-throughput metabolite detection combined with bioinformatics is effective.
• Studies indicate potential for discovering new biochemical pathways and predictive biomarkers.

Conclusions:

• Metabolomics shows potential for advancing non-invasive prenatal diagnostics.
• Current findings are preliminary, requiring larger sample sizes and rigorous validation.
• Further research is essential to translate metabolomics discoveries into clinical practice for fetal and perinatal health.